Drug Approval Package

Reminyl (Galantamine Hydrobromide) Oral Solution
Company:  Janssen Research Foundation
Application No.:  21-224
Approval Date: 6/22/2001

• Approval Letter(s) (PDF)  

• Printed Labeling (PDF)  

• Medical Review(s) (PDF)  

• Chemistry Review(s) (PDF)  

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)  

• Administrative Document(s) (PDF)  

• Correspondence (PDF)

Date created: November 20, 2001

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.